/MCURF

MCURF Stock - Mind Cure Health Inc.

Q: What is the analyst price target for MCURF?

Analyst price target information is not currently available for MCURF.

Q: What is MCURF's market cap?

Market capitalization information is not currently available for MCURF.

Healthcare|Biotechnology|OTC

$0.51+971.88%

+$0.46 (+971.88%) • Sep 11

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.56

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MCURF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.26

52W High$0.51

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021
Revenue	N/A	N/A
Gross Profit	N/A	N/A
Gross Margin	N/A	N/A
Operating Income	$-5,893,621	$-10,725,827
Net Income	$-14,141,082	$-10,173,348
Net Margin	N/A	N/A
EPS	$-0.15	$-0.18

Company Overview

Mind Cure Health Inc., a life sciences company, develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy. The company develops iSTRYM, a digital therapeutics tool and first-of-its-kind software application that optimizes the healing journey for patients and clinicians before, during, and after therapy sessions; PsyCollage, a bioinformatics platform that helps to drive research by identifying priority research programs; synthetic ibogaine to supply researchers and clinicians; and psychedelic compounds, including ibogaine for traumatic brain injuries and related conditions. Mind Cure Health Inc. was incorporated in 2020 and is headquartered in Vancouver, Canada.

Visit Website

Earnings History & Surprises

MCURF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q2 2024

EPS Surprise History

Q2 22

No data

Q2 22

No data

Q3 22

No data

Q1 23

No data

Q2 23

No data

Q4 23

No data

Q1 24

No data

Q2 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	Apr 18, 2024	—	$-0.00	—	—
Q1 2024	Jan 23, 2024	—	$-0.00	—	—
Q4 2023	Oct 24, 2023	—	$-0.00	—	—
Q2 2023	Apr 20, 2023	—	$-0.03	—	—
Q1 2023	Jan 25, 2023	—	$-0.02	—	—
Q3 2022	Sep 13, 2022	—	$-0.02	—	—
Q2 2022	May 31, 2022	—	$-0.04	—	—
Q2 2022	Apr 26, 2022	—	$-0.04	—	—
Q1 2022	Jan 25, 2022	—	$-0.06	—	—
Q4 2021	Oct 26, 2021	—	$-0.01	—	—
Q2 2021	May 31, 2021	—	$-0.06	—	—
Q2 2020	May 31, 2020	—	$-0.00	—	—